These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24700295)

  • 1. Caprylate-conjugated Cisplatin for the development of novel liposomal formulation.
    Vhora I; Khatri N; Desai J; Thakkar HP
    AAPS PharmSciTech; 2014 Aug; 15(4):845-57. PubMed ID: 24700295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-octadecylcarbamoylacrylic acid-cisplatin nanocomplexes for the development of novel liposome formulation.
    Song J; Xu T; Zhang Y; Guo H; Ren W; Zhu S; Yang L
    Drug Deliv; 2016 Nov; 23(9):3285-3293. PubMed ID: 27028975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor.
    Zhao Y; May JP; Chen IW; Undzys E; Li SD
    Pharm Res; 2015 Oct; 32(10):3261-8. PubMed ID: 25964047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Perez-Soler R; Khokhar AR
    Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol.
    Basavaraj S; Betageri GV
    Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance.
    Peleg-Shulman T; Gibson D; Cohen R; Abra R; Barenholz Y
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):278-91. PubMed ID: 11342165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a liposomal formulation of the natural flavonoid fisetin.
    Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
    Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of boanmycin-loaded liposomes prepared by pH gradient experimental design.
    Liu Y; Yoo SD; Li L; Fang L; Wen Z; Li T
    Drug Deliv; 2012 Feb; 19(2):90-101. PubMed ID: 22283679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Entrapment of 4-Nerolidylcatechol: Impact on Phospholipid Dynamics, Drug Stability and Bioactivity.
    Gaetil MP; Benfica PL; Mendes LP; Vieira MS; Anjos JL; Alonso A; Rezende KR; Valadares MC; Lima EM
    J Nanosci Nanotechnol; 2015 Jan; 15(1):838-47. PubMed ID: 26328448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids.
    Kieler-Ferguson HM; Chan D; Sockolosky J; Finney L; Maxey E; Vogt S; Szoka FC
    Eur J Pharm Sci; 2017 May; 103():85-93. PubMed ID: 28263913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
    Pereira S; Egbu R; Jannati G; Al-Jamal WT
    Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability.
    Byeon JC; Lee SE; Kim TH; Ahn JB; Kim DH; Choi JS; Park JS
    Drug Deliv; 2019 Dec; 26(1):216-225. PubMed ID: 30843439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.
    Poy D; Akbarzadeh A; Ebrahimi Shahmabadi H; Ebrahimifar M; Farhangi A; Farahnak Zarabi M; Akbari A; Saffari Z; Siami F
    Chem Biol Drug Des; 2016 Oct; 88(4):568-73. PubMed ID: 27178305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation.
    Yang Z; Liu J; Gao J; Chen S; Huang G
    Int J Pharm; 2015 Nov; 495(1):508-515. PubMed ID: 26325316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.